HRT 'reduces mortality risk in 50s'

HRT reduces mortality in women in their mid-50s, an analysis of data from 16,000 women has shown.

HRT: benefits greaterin mid 50's
HRT: benefits greaterin mid 50's

Dr Shelley Salpeter and colleagues at Santa Clara Medical Centre, California, examined 19 studies involving 16,283 women with a mean age of 55 years.

They found HRT was associated with a 27 per cent reduction in relative mortality risk and an absolute risk reduction of around 1 per cent.

The research, published in the American Journal of Medicine, sought to 'make sense of the accumulated evidence' on HRT. The researchers specifically wanted to address concerns raised by a 2002 study of data from the Women's Health Initiative (WHI).

The WHI study showed women aged over 63 years had an increased risk of developing a variety of conditions. This led to the assumption that HRT might increase health risks in all women and that these risks raised women's mortality risk.

Dr Salpeter believes the WHI results have been poorly inter-preted. She hoped the new study would help clarify the role of HRT in younger women.

The researchers stressed their findings needed to be interpreted in light of potential benefits and harms of hormone therapy.

'Available evidence indicates that hormone therapy in younger postmenopausal women increases the risk of breast cancer and pulmonary embolism, and reduces risk of cardiovascular events, colon cancer, and hip fracture,' they said.

'The total mortality benefit for younger women seen in the randomised trials and observa-tional studies indicates that the reduction in deaths from coronary heart disease, fracture, and colon cancer outweighed the increase in deaths from breast cancer, stroke, and pulmonary embolism,' the researchers added.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Half of patients with possible cancer symptoms avoided contacting GP in first wave

Half of patients with possible cancer symptoms avoided contacting GP in first wave

Almost half of people who experienced potential cancer symptoms in the first wave...

GP premises need major investment to let PCNs recruit, warns BMA

GP premises need major investment to let PCNs recruit, warns BMA

Primary care networks (PCNs) are struggling to make use of hundreds of millions of...

NHS unveils £4.2m fund to tackle vaccine inequality

NHS unveils £4.2m fund to tackle vaccine inequality

CCGs with low uptake of COVID-19 vaccine in ethnic minority, marginalised or deprived...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

150,000 more people with learning disabilities prioritised for COVID-19 vaccine

150,000 more people with learning disabilities prioritised for COVID-19 vaccine

Around 150,000 more people will be prioritised for COVID-19 vaccination after the...

Dilemma: What should I do if a practice staff member refuses the COVID-19 vaccine?

Dilemma: What should I do if a practice staff member refuses the COVID-19 vaccine?

Dr Peter Mackenzie and Ceylan Simsek from Medical Protection offer some guidance...